SUNNYVALE, CA--(Marketwired - May 2, 2013) - Spiracur Inc . announced today that it is showcasing its full suite of advanced wound care solutions with the proven efficacy of Negative Pressure Wound Therapy (NPWT), including the newly introduced SNaP ® SecurRing™ Hydrocolloid, the SNaP Bridge Dressing for plantar surface wound care, and its flagship, the SNaP Wound Care System for the treatment of chronic and acute wounds, at the Symposium for Advanced Wound Care (SAWC) Spring Conference this week in Denver, Colo. The SAWC is the premier interdisciplinary wound care program and the largest annual gathering of wound care clinicians in the United States.
The company also announced that Gary Rothenberg, DPM, CDE, CWS, director of Residency Training and Attending Podiatrist at the Miami Veterans Affairs Healthcare System will present a clinical poster entitled, "Advances for Negative Pressure Wound Therapy in Challenging Anatomic Locations," during the SAWC. The poster describes the utilization of NPWT on a wound that otherwise would have been difficult to seal without the SNaP SecurRing Hydrocolloid. Spiracur's SecurRing is designed to facilitate fast and easy applications of the SNaP Wound Care System on uneven skin surfaces or wounds in challenging locations, and is intended for patients suffering from chronic wounds such as diabetic foot ulcers (DFU), or wounds to the plantar surface of the foot, and acute wounds, such as ray amputations.
"The SecurRing Hydrocolloid is an ideal solution for our clinic because it makes dressing applications faster and easier on a large number of our patients suffering from DFUs, ray amputations and plantar wounds," said Dr. Rothenberg. "When using the SecurRing Hydrocolloid, fewer accessories are required and less time is needed to get a seal. In addition, by using it with the SNaP Dressing, we can now apply NPWT in challenging anatomic locations, which would not have been previously considered."
Spiracur is also educating attendees about reimbursement to cover NPWT delivered by a mechanically-powered device in wound care clinics and physician offices, while showcasing the SNaP system as an effective, off-the-shelf solution clinics and physicians can offer their patients earlier in the wound care treatment process. The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services (CMS), established two Healthcare Common Procedure Coding System (HCPCS) codes ( G0456 and G0457 ) for NPWT using a mechanically powered device in January 2013.
"We are proud to offer clinicians and their patients our effective, easy-to-use wound care solutions for the successful treatment of chronic and acute wounds," said Gary Restani , president and chief executive officer for Spiracur Inc. "For clinicians, the SNaP System, the SecurRing Hydrocolloid and the Bridge Dressing are very easy to apply. Our products are small, lightweight and offer discreetness for our patients. In addition, our innovative technology is proven to deliver NPWT that may help heal patients' wounds more rapidly, while also alleviating the rental or procurement process."
Spiracur is credited with creating a new category of chronic and acute wound management solutions by combining the benefits of advanced wound care with the proven efficacy of NPWT. The benefits of the SNaP Wound Care System have been recognized by a number of payers including large private insurance companies and the Veterans Administration Health Care Services, with over 37,000 total applications to date. In addition, a multitude of studies have been published supporting the SNaP Wound Care System as an effective alternative to powered NPWT, including a comparative Randomized Controlled Trial that also showed the powerful, small device makes a positive difference in patients' quality of life .
About Spiracur Inc. Spiracur Inc ., headquartered in Sunnyvale, Calif., is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford University Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System for the treatment of chronic and acute wounds, is the result of patient and clinician feedback that current negative pressure wound therapies were too cumbersome. The company's ciSNaP® Closed Incision System with proprietary controlled tension relief is designed to improve healing of high-risk surgical incisions. Both devices have been cleared by the U.S. Food & Drug Administration (FDA) and have received CE Mark approval. For more information, please visit http://spiracur.com .
Spiracur, Spiracur logo, SNaP and SNaP & Design are registered trademarks of Spiracur Inc. SecurRing is a trademark of Spiracur Inc.
Media Contact: Amy Cook 925.552.7893 Email Contact Investor Contact: Steve Van Dick 408.701.5300 Email Contact
